AstraZeneca has submitted the first marketing application in Europe for its immunotherapy Imfinzi, seeking approval for the drug’s use to treat a subset of patients with lung cancer.
News
Depression affects nearly half of older adults in the UK
Nearly half of UK adults aged over 55 say they have experienced depression, according to a YouGov survey carried out for Age UK, highlighting the scale of the mental health challenge facing this age group.
Bayer halts Xarelto trial
Trial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS).
Cell and Gene Therapy Catapult in new stem-cell deal
Will provide its induced Pluripotent Stem Cell line to Universal Cells for use in its universal donor cell line
US court throws out Praluent sales ban
Says original Amgen/Sanofi trial jury was not properly instructed
Most cancer drugs approved by EMA show little benefit: study
Only 35% of approved medicines between 2009-13 showed significant survival benefit at approval
Positive results for DNA-based Zika Vaccine
Vaccine is being developed by Inovio and GeneOne
High Court dismisses ABPI’s review of new NICE rules
ABPI sought to challenge rationing of drugs costing over £20m
Amgen announces new T-cell collaboration
Will team with CytomX Therapeutics on Probody T-cell engaging bispecific
FDA approves Mylan’s generic Copaxone
Teva’s drug is most prescribed treatment for relapsing forms of MS in the US
Shire sues Allergan in dry eye disagreement
Shire alleges that Allergan is in effect blocking competition in Medicare drug plans
FDA guidance aims to boost generic competition
Measures will ease the development and approval of complex generic drugs
‘Universal’ flu vaccine to be tested
Vaccine uses T-cells to potentially attack multiple strains of the virus
US steps up Ebola response
With gill a total of $170m to MSD, Janssen, Mapp and Regeneron
Ablynx scores with blood clot drug
Caplacizumab shows promise in rare, life-threatening autoimmune blood clotting disorder.
